营养保健品市场按产品类型、形式、应用和地区划分（2026-2032 年）

营养保健品市场评估（2026-2032）

消费者健康意识的不断增强，越来越多地转向预防性保健解决方案和营养补充剂来管理与文明病，这是推动营养保健品市场发展的主要因素。预计到2024年，营养保健品市场的收益将达到3,842.7亿美元，到2032年将达到4,537.8亿美元。

科技和研究的进步正在催生创新的营养保健品配方，市场从 2026 年到 2032 年的复合年增长率将达到 2.10%。

营养保健品市场定义/概述

营养保健品是指提供超越基本营养的健康益处的食品，通常用于维持健康或预防疾病。这个术语由「营养」和「药物」两个词组合而成，涵盖范围广泛，包括膳食补充剂、机能性食品和草药。

人们认为营养保健品具有生理益处，可以预防慢性疾病，并有助于促进健康、延缓老化以及增强身体结构和功能。虽然营养保健品来自食品，但它们通常以类似药物的形式销售，并且可能没有经过与药物同等严格的科学检验。各国对营养保健品的监管状况各不相同，有些国家将其视为食品或补充剂，而非药物。

人口老化将在营养保健品市场的成长中发挥什么作用？

高龄化社会被认为是营养保健品市场成长的关键驱动力。据报道，到2030年，全球六分之一的人口将达到60岁或以上，凸显了针对这一人群量身定制的健康解决方案的紧迫性。随着人口老化，人们越来越重视预防与老龄化相关的疾病，这推动了对促进关节健康、认知功能和心血管健康的膳食补充剂和机能性食品的需求。

根据政府统计，与慢性病相关的医疗费用正在上升，鼓励老年人透过营养保健品采取预防性医疗措施。

此外，研究表明，老年人越来越倾向于将营养补充剂纳入日常生活，这进一步扩大了该领域的成长空间。随着越来越多的人将透过食用营养保健品来维护健康和预防疾病作为优先事项，预计这种人口结构变化将继续影响市场趋势。

营养保健品市场在品管和标准化方面面临的主要挑战是什么？

品管和标准化是营养保健品市场面临的主要挑战，主要原因是与药品相比，营养保健品市场缺乏严格的监管标准。据报道，约70%的消费者对膳食补充剂的品质和安全表示担忧，这凸显了建立强有力的品质保证措施的必要性。成分的自然差异往往会导致批次间产品不一致，从而损害产品功效并削弱消费者信心。

政府统计数据显示，许多製造商未能遵守良好生产规范 (GMP)，导致生产过程中存在污染和品质问题的风险。因此，维持高品质标准的责任日益落在个体製造商身上，他们必须执行严格的测试通讯协定，并确保整个生产过程的可追溯性。由于缺乏普遍认可的品质基准，营养保健品产业在确保产品真实性和消费者安全方面仍面临重大挑战。

目录

第 1 章全球营养保健品市场：简介

• 市场概览
• 分析范围
• 先决条件

第二章执行摘要

第三章 已验证的市场研究分析方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章全球营养保健品市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章。全球营养保健品市场（依产品类型）

• 概述
• 营养补充品
• 机能性食品
• 医学营养
• 机能饮料

6. 全球营养保健品市场（依形式）

• 概述
• 锭剂
• 粉末
• 液体
• 软糖

7. 全球营养保健品市场（按应用）

• 概述
• 预防医学
• 疾病管理
• 体重管理
• 抗衰老

8. 全球营养保健品市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他地区 (ROW)
  • 拉丁美洲
  • 中东和非洲

第九章全球营养保健品市场的竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第十章 公司简介

• Pfizer Inc.
• Nestle Health Science SA
• Amway Corporation
• Herbalife Nutrition Ltd.
• DSM
• The Hain Celestial Group, Inc.
• Abbott Laboratories
• Danone SA
• Sun Pharmaceutical Industries Ltd.
• NutraLife Corporation

第十一章 附录

• 相关分析

Nutraceutical Market Valuation - 2026-2032

The increasing health consciousness among consumers, who are more inclined to seek preventive healthcare solutions and dietary supplements to manage lifestyle-related disorders are the primary factor driving the nutraceutical market. The Nutraceutical Market is estimated to reach a valuation of USD 453.78 Billion by 2032 over the forecast by subjugating the revenue of USD 384.27 Billion valued in 2024.

Advancements in technology and research have led to innovative nutraceutical formulations, enabling the market to grow at a CAGR of 2.10% from 2026 to 2032.

Nutraceutical Market: Definition/ Overview

A nutraceutical is defined as a food product that provides health benefits beyond basic nutrition, often used to maintain health and prevent illness. The term, which combines "nutrition" and "pharmaceutical," encompasses a wide range of products, including dietary supplements, functional foods, and herbal remedies.

Nutraceuticals are believed to offer physiological benefits or protection against chronic diseases and can be utilized to improve health, delay aging, and enhance the body's structure or function. While they are derived from food sources, nutraceuticals are typically marketed in forms resembling medicinal products and may not have undergone the same rigorous scientific validation as pharmaceuticals. The regulatory status of nutraceuticals varies by country, with some jurisdictions treating them as foods or dietary supplements rather than drugs.

What Role does the Aging Population Play in Driving the Growth of the Nutraceutical Market?

The aging population is recognized as a significant driver of growth in the nutraceutical market, as an increasing number of individuals over the age of 65 are seeking products that support their health and well-being. It has been reported that by 2030, one in six people worldwide will be aged 60 years or older, highlighting the urgency for health-focused solutions tailored to this demographic. As people age, there is a heightened emphasis on preventing age-related diseases, leading to a greater demand for dietary supplements and functional foods that promote joint health, cognitive function, and cardiovascular wellness.

Government statistics indicate that healthcare costs associated with chronic diseases are rising, prompting older adults to adopt preventive healthcare measures through nutraceuticals.

Additionally, studies have shown that older adults are increasingly recommended to incorporate dietary supplements into their daily routines, further boosting the scope for growth in this sector. This demographic shift is expected to continue influencing market trends as more individuals prioritize health maintenance and disease prevention through nutraceutical consumption.

What are the Main Challenges Related to Quality Control and Standardization in the Nutraceutical Market?

Quality control and standardization are major challenges in the nutraceutical market, primarily due to the lack of stringent regulatory standards compared to pharmaceuticals. It has been reported that approximately 70% of consumers express concerns regarding the quality and safety of dietary supplements, which underscores the necessity for robust quality assurance measures. The natural variability of ingredients often results in batch-to-batch inconsistencies, potentially compromising product efficacy and eroding consumer trust.

Government statistics highlight that many manufacturers fail to adhere to Good Manufacturing Practices (GMP), leading to risks of contamination and quality issues during production. As a result, the responsibility for maintaining high-quality standards increasingly falls on individual manufacturers, who must implement rigorous testing protocols and ensure traceability throughout the production process. Without universally accepted benchmarks for quality, significant challenges persist in ensuring product reliability and consumer safety within the nutraceutical industry.

Category-Wise Acumens

How do Consumer Preferences for Natural Health Solutions Contribute to the Dominance of Dietary Supplements in the Nutraceutical Market?

Consumer preferences for natural health solutions significantly contribute to the dominance of dietary supplements in the nutraceutical market, as an increasing number of individuals are gravitating towards products perceived as safer and more effective for health maintenance. It has been reported that approximately 70% of consumers express a preference for natural ingredients, particularly for preventive health measures rather than curative ones, indicating a strong inclination towards dietary supplements that promise enhanced well-being without the side effects often associated with synthetic medications.

Government statistics from the Ministry of Food Processing Industries highlight a notable shift in purchasing patterns, with many consumers now favoring immunity-boosting supplements and herbal products over traditional pharmaceuticals for minor health issues. This trend is further supported by a growing awareness of the health benefits associated with dietary supplements, which is reflected in the increasing consumer willingness to invest in products that align with their values of sustainability and natural wellness. As a result, the nutraceutical market is being shaped by these evolving consumer preferences, leading to a robust demand for dietary supplements that cater to the desire for holistic health solutions.

How has the COVID-19 Pandemic Influenced the Emphasis on Preventive Healthcare Within the Nutraceutical Market?

The COVID-19 pandemic has significantly influenced the emphasis on preventive healthcare within the nutraceutical market, as consumers increasingly seek solutions to enhance their immunity and overall health. It has been observed that the demand for dietary supplements surged during the pandemic, with many individuals turning to nutraceuticals as a proactive measure against health threats. Government data from the Food Safety and Standards Authority of India (FSSAI) indicate that there was a notable shift in consumer behavior, with a marked increase in the purchase of immunity-boosting supplements such as vitamins C and D, zinc, and probiotics. Approximately 15% of India's population is reported to be undernourished, highlighting the critical role that nutraceuticals can play in addressing nutritional deficiencies exacerbated by the pandemic.

Furthermore, initiatives such as the National Health Mission have underscored the importance of nutrition in public health policies, thereby reinforcing the relevance of nutraceuticals as essential components of preventive healthcare strategies. As a result, a lasting impact on consumer attitudes towards health and wellness has been established, positioning nutraceuticals as vital tools in promoting preventive care in a post-pandemic world.

What Factors Contribute to North America's Position as a Leader in the Nutraceutical Market?

North America's position as a leader in the global nutraceutical market is influenced by several key factors, primarily driven by consumer demand for health-focused products. It has been reported that approximately 35.2% of the nutraceutical market share is held by this region, reflecting a strong preference for preventive healthcare solutions among consumers. Government statistics from the Centers for Disease Control and Prevention (CDC) indicate that nearly 70% of adults in the U.S. are seeking dietary supplements to enhance their health and prevent chronic diseases. The aging population in North America also plays a crucial role, as older adults increasingly turn to nutraceuticals to manage age-related health issues.

Additionally, rising healthcare costs, which account for about 14% of the U.S. gross national product, have prompted consumers to seek cost-effective preventive measures through dietary supplements and functional foods. Furthermore, regulatory support for functional food innovations and increased research and development efforts by companies are fostering a competitive environment that enhances product availability and consumer trust in nutraceuticals. As a result, these factors collectively contribute to North America's dominant position in the nutraceutical market.

What Factors Contribute to the Rapid Growth of the Nutraceutical Market in Asia Pacific Region?

The rapid growth of the nutraceutical market in the Asia Pacific region is driven by several key factors, primarily related to changing consumer preferences and increasing health awareness. It has been reported that approximately 40% of the demand for nutraceuticals originated from Asia Pacific in 2022, reflecting a strong regional inclination towards preventive healthcare solutions. Government statistics from the World Health Organization indicate that the prevalence of chronic diseases such as diabetes and cardiovascular conditions is rising, prompting consumers to seek dietary supplements to enhance their health and immunity.

Additionally, various government initiatives, including the Poshan Abhiyan in India aimed at eradicating malnutrition, have promoted awareness about the importance of nutrition in disease prevention. Furthermore, the legalization of hemp cultivation in several countries has led to an increase in cannabis-based nutraceutical products, catering to evolving consumer interests. As a result, these factors collectively contribute to the dynamic expansion of the nutraceutical market in the Asia Pacific region, positioning it as a significant player on the global stage.

Competitive Landscape

The competitive landscape of the nutraceutical market is characterized by a mix of established international players and emerging companies, all striving for market share through innovation and strategic initiatives. The rising trend of veganism and clean-label products is influencing product formulations, leading to increased demand for botanical ingredients. With an advanced distribution network supporting these efforts, the competitive dynamics within the nutraceutical market are expected to continue evolving as companies adapt to changing consumer preferences and health trends.

Some of the prominent players operating in the nutraceutical market include:

Pfizer,

Nestle Health Science A.

Amway Corporation

Herbalife Nutrition

DSM

The Hain Celestial Group,

Abbott Laboratories

Danone A.

Sun Pharmaceutical Industries

NutraLife Corporation

Latest Developments

In March 2023, Pfizer announced a definitive merger agreement to acquire Seagen Inc. for USD 43 Billion, aiming to enhance its oncology portfolio and potentially expand into nutraceutical applications that support cancer treatment and overall health.

In February 2023, DSM launched life's(R)OMEGA O3020, a new algal oil product aimed at providing a sustainable alternative to fish oil, addressing consumer demand for plant-based omega-3 fatty acids.

Nutraceutical Market, By Category Product Type:

• Dietary Supplements
• Functional Foods
• Medical Nutrition
• Functional Beverages
• Form:
• Tablets
• Powders
• Liquids
• Gummies
• Application:
• Preventive Healthcare
• Disease Management
• Weight Management
• Anti-Aging
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NUTRACEUTICAL MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NUTRACEUTICAL MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NUTRACEUTICAL MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Dietary Supplements
• 5.3 Functional Foods
• 5.4 Medical Nutrition
• 5.5 Functional Beverages

6 GLOBAL NUTRACEUTICAL MARKET, BY FORM

• 6.1 Overview
• 6.2 Tablets
• 6.3 Powders
• 6.4 Liquids
• 6.5 Gummies

7 GLOBAL NUTRACEUTICAL MARKET, BY APPLICATION

• 7.1 Overview
• 7.2 Preventive Healthcare
• 7.3 Disease Management
• 7.4 Weight Management
• 7.5 Anti-Aging

8 GLOBAL NUTRACEUTICAL MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL NUTRACEUTICAL MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Pfizer Inc.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Nestle Health Science S.A.
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Amway Corporation
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Herbalife Nutrition Ltd.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 DSM
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 The Hain Celestial Group, Inc.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Abbott Laboratories
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Danone S.A.
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Sun Pharmaceutical Industries Ltd.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 NutraLife Corporation
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Reports